- Home
- FURY vs ZYXI Comparison
FURY vs ZYXI Comparison
Compare FURY & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- ZYXI
- Stock Information
- Founded
- FURY 2008
- ZYXI 1996
- Country
- FURY Canada
- ZYXI United States
- Employees
- FURY N/A
- ZYXI N/A
- Industry
- FURY Precious Metals
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FURY Basic Materials
- ZYXI Health Care
- Exchange
- FURY Nasdaq
- ZYXI Nasdaq
- Market Cap
- FURY 60.5M
- ZYXI 66.5M
- IPO Year
- FURY N/A
- ZYXI N/A
- Fundamental
- Price
- FURY $0.39
- ZYXI $2.18
- Analyst Decision
- FURY Strong Buy
- ZYXI Buy
- Analyst Count
- FURY 1
- ZYXI 3
- Target Price
- FURY $1.10
- ZYXI $10.25
- AVG Volume (30 Days)
- FURY 154.5K
- ZYXI 262.3K
- Earning Date
- FURY 05-13-2025
- ZYXI 04-29-2025
- Dividend Yield
- FURY N/A
- ZYXI N/A
- EPS Growth
- FURY N/A
- ZYXI N/A
- EPS
- FURY N/A
- ZYXI 0.09
- Revenue
- FURY N/A
- ZYXI $192,354,000.00
- Revenue This Year
- FURY N/A
- ZYXI N/A
- Revenue Next Year
- FURY N/A
- ZYXI $23.16
- P/E Ratio
- FURY N/A
- ZYXI $24.22
- Revenue Growth
- FURY N/A
- ZYXI 4.36
- 52 Week Low
- FURY $0.35
- ZYXI $1.93
- 52 Week High
- FURY $0.57
- ZYXI $12.19
- Technical
- Relative Strength Index (RSI)
- FURY 53.97
- ZYXI 26.14
- Support Level
- FURY $0.35
- ZYXI $2.03
- Resistance Level
- FURY $0.41
- ZYXI $2.24
- Average True Range (ATR)
- FURY 0.02
- ZYXI 0.18
- MACD
- FURY 0.00
- ZYXI 0.17
- Stochastic Oscillator
- FURY 73.77
- ZYXI 38.46
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.